Stay updated with breaking news from Nasdaq avte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Hunter Gillies sold 3,489 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $20.23, for a total value of $70,582.47. Following the transaction, the insider now directly owns 3,251 shares of the company’s stock, […] ....
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares traded up 10.8% during mid-day trading on Thursday . The company traded as high as $21.34 and last traded at $21.32. 43,510 shares were traded during mid-day trading, a decline of 50% from the average session volume of 86,833 shares. The stock had previously closed at […] ....
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Ralph Niven sold 4,600 shares of the company’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $17.45, for a total value of $80,270.00. Following the completion of the sale, the insider now owns 1,609 shares of the […] ....
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 84,148 shares traded hands during mid-day trading, an increase of 51% from the previous session’s volume of 55,596 shares.The stock last traded at $18.82 and had previously closed at $19.15. Analysts Set New Price Targets A number of research […] ....
Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report) and Sol-Gel Technologies (NASDAQ:SLGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Volatility & Risk Aerovate Therapeutics has a […] ....